Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Wire Hong Kong.
HUTCHMED Announces Appointment of Acting Chief Executive Officer
GlobeNewswire, Inc.
·
August 25, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence...
UM hosts Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum
Macao Government News
·
August 22, 2025
MACAU, August 22 - The Institute of Advanced Studies in Humanities and Social Sciences (IAS) at the University of Macau (UM) held the 3rd Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum. The two-day forum brought...
IAM and Ocean Park Hong Kong sign memorandum of intent for conservation cooperation
Macao Government News
·
August 21, 2025
MACAU, August 21 - The delegation of the representatives of Ocean Park Hong Kong visited the Municipal Affairs Bureau (IAM) today (21 August). Both parties signed the “Memorandum of Intent for Conservation Cooperation between Municipal Affairs...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire, Inc.
·
August 21, 2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
GlobeNewswire, Inc.
·
August 20, 2025
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following...
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
GlobeNewswire, Inc.
·
August 17, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel,...
UM to host the Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum
Macao Government News
·
August 11, 2025
MACAU, August 11 - To foster academic exchange and development in the Guangdong-Hong Kong-Macao Greater Bay Area and to create a platform for interdisciplinary dialogue on global issues, the Institute of Advanced Studies in Humanities and Social...
FED Fitness Expands Its Amazon Best Seller Lineup: Shaping the Future of Home Fitness for Quality-Focused Families
GlobeNewswire, Inc.
·
August 23, 2025
Hong Kong, China , Aug. 23, 2025 (GLOBE NEWSWIRE) -- FED Fitness is taking a bold step forward in redefining what home fitness can be. With the official launch of its Amazon Best Seller product series, the brand is not just offering top-rated...
HydroGraph Partners with Hawkeye Bio to Power Novel Graphene Biosensor Solution for LEAP™ Lung Cancer Test from Ease Healthcare
GlobeNewswire, Inc.
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced its role in a new lung cancer screening product underpinning a...
Asian Beauty Leader NutriWorks Brings Natural Wellness to Retail Innovator ECRM This September
EIN Presswire
·
August 12, 2025
BOCA RATON, FL, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- The popularity of natural self-care products is on the rise, with the global Natural and Organic Cosmetics market projected to hit $15.7 billion dollars this year according to...
Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, “From Traditional Insurance Broker to Tech-Based Health Insurance Innovator”
GlobeNewswire, Inc.
·
August 7, 2025
ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ: TIRX) titled, “From Traditional Insurance Broker to...
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
GlobeNewswire, Inc.
·
August 7, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical...
Cincinnati CBP seized $3.5 million in counterfeit pharma
U.S. Customs and Border Protection
·
August 7, 2025
CINCINNATI–During a week-long joint operation between U.S. Customs and Border Protection and U.S. Food and Drug Administration, CBP officers inspected hundreds of boxes containing possible counterfeit and unapproved medications. A wide variety of...
FEIERDUN Debuts 52.5LB Adjustable Dumbbell Pair, Setting a New Standard for Home Strength Training
GlobeNewswire, Inc.
·
August 22, 2025
Hong Kong, Aug. 22, 2025 (GLOBE NEWSWIRE) -- As the home fitness market continues to evolve, FED Fitness continues to lead the way through its specialized product lines — including FEIERDUN, a customer-oriented fitness equipment line founded in...
Hello Nancy Named 2025 Women’s Wellness Tech Award Winner
GlobeNewswire, Inc.
·
August 6, 2025
Sheung Wan, Hong Kong, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hello Nancy, the innovative wellness brand championing female empowerment and self-care, today announced it has been named a winner of the prestigious 2025 Women’s Wellness Tech Award. The...
NovaX Global Investmatch Carnival 2025 Concludes Successfully
EIN Presswire
·
August 20, 2025
NovaX Global Investmatch Carnival 2025 Concludes Successfully, Catalysing Over 1,000 Investment Matches as Global Tech Elite Converge in Hong Kong HONG KONG, KWUN TONG, HONG KONG, August 20, 2025 /EINPresswire.com/ -- The NovaX Global...
Ascentage Pharma to Participate in Evercore China Biotech Summit
GlobeNewswire, Inc.
·
August 1, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical...
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
GlobeNewswire, Inc.
·
July 30, 2025
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe...
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
GlobeNewswire, Inc.
·
August 20, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS®...
InnoCare Announces First Patient Dosed in the Registrational Trial of BCL2 Inhibitor Mesutoclax for Treatment of BTKi-treated MCL Patients in China
GlobeNewswire, Inc.
·
August 21, 2025
BEIJING, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the...